The role of XPB in cell apoptosis and viability and its relationship with p53, p21waf1/cip1 and c-myc in hepatoma cells

Digestive and Liver Disease

Volumn 38, Issue 10, 2006, Pages 755-761

  Hu, G m ^a   Liu, L m ^a,b   Zhang, J x ^a,b   Hu, X d ^b   Duan, H j ^b   Deng, H ^a   He, M ^a   Luo, Z j ^a   Liu, J m ^a   Luo, J ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Province Key Laboratory of Molecular Medicine   (China)

Author keywords

Apoptosis; c myc; Hepatoma; p21waf1 cip1; p53; Viability; XPB

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 3; HELICASE; MYC PROTEIN; PLASMID DNA; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; NICK END LABELING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA HELICASES; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33748512589     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.06.009     Document Type: Article

References (30)

1. Bernstein C., Bernstein H., Payne C.M., and Garewal H. DNA repair/pro-apototic dual-role proteins in five major DNA repair pathway: fail-safe protection against carcinogenesis. Mutat Res 511 (2002) 145-178
2. Bootsma D., and Hoeijmakers J.H. The molecular basis of nucleotide excision repair syndromes. Mutat Res 307 (1994) 15-23
3. Sancar A. DNA excision repair. Annu Rev Biochem 65 (1996) 43-81
4. Coin F., Bergmann E., Tremeau-Bravard A., and Egly J.M. Mutation in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. Eur Mol Biol Organ J 18 (1999) 1357-1366
5. de Laat W.L., Jaspers N.G., and Hoeijmakers J.H. Molecular mechanism of nucleotide excision repair. Genes Dev 13 (1999) 768-785
6. Flores O., Lu H., and Reinberg D. Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of factor IIH. J Biol Chem 267 (1992) 2786-2793
7. Coin F., Auriol J., Tapias A., Clivio P., Vermeulen W., and Egly J.M. Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity. Eur Mol Biol Organ J 23 (2004) 4835-4846
8. Wakasugi M., and Sancar A. Assembly, subunit composition, and footprint of human DNA repair excision nuclease. Proc Natl Acad Sci USA 95 (1998) 6669-6674
9. Cleaver J.E. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups xeroderma pigmentosum. J Dermatol Sci 23 (2000) 1-11
10. Ishikawa T., Samuel S.M.Z., Qin X.S., Takahashi Y., Oda H., Naketsuru Y., et al. DNA repair and cancer: lessons from mutant mouse models. Cancer Sci 95 (2004) 112-117
11. Cheng L., Sturgis E.M., Eicher S.A., Spitz M.R., and Wei Q. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94 (2002) 393-397
12. Takebayashi Y., Nakayama K., Kanzaki A., Miyashita H., Ogura O., Mori S., et al. Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors. Cancer Lett 174 (2001) 115-125
13. Miyashita H., Mori S., Tanda N., Nakayama K., Kanzaki A., Sato A., et al. Loss of heterozygosity of nucleotide excision repair factors in sporadic oral squamous cell carcinoma using microdissected tissue. Oncol Rep 8 (2001) 1133-1138
14. Wilson D.M., and Thompson L.H. Life without DNA repair. Proc Natl Acad Sci USA 94 (1997) 12754-12757
15. Jaitovich-Groisman I., Benlimame N., Slagle B.L., Perez M.H., Alpert L., Song D.J., et al. Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissues. J Biol Chem 276 (2001) 14124-14132
16. Robles A.I., and Harris C.C. p53-mediated apoptosis and genomic instability deseases. Acta Oncol 40 (2001) 696-701
17. Capovilla A., and Arbuthnot P. Nucleotide excision repair by extracts of human fetal hepatocytes. FEBS Lett 518 (2002) 144-148
18. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
19. Fei P., and El-Deiry W.S. p53 and radiation responses. Oncogene 22 (2003) 5774-5783
20. waf1/cip1-induced apoptosis in human ovarian cancer cells. J Biol Chem 277 (2002) 36329-36337
21. WAF1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13 (2002) 453-464
22. Bissonnette N., Wasylyk B., and Hunting D.J. The apoptotic and transcriptional transactivation activities of p53 can be dissociated. Biochem Cell Biol 75 (1997) 351-358
23. Wang X.W., Vermeulen W., Coursen J.D., Gibson M., Lupold S.E., Forrester K., et al. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10 (1996) 1219-1232
24. Grandori C., Cowley S.M., James L.P., and Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16 (2000) 653-699
25. Peng S.Y., Lai P.L., and Hsu H.C. Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance. J Formos Med Assoc 92 (1993) 866-870
26. Hironaka K., Factor V.M., Calvisi D.F., Conner E.A., and Thorgeirsson S.S. Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. Lab Invest 83 (2003) 643-654
27. Liu J., Akoulitchev S., Weber A., Ge H., Chuikov S., Libutti D., et al. Defective interplay of activators and repressors with TFIIH in Xeroderma Pigmentosum. Cell 104 (2001) 353-363
28. He L., Liu J., Collins I., Sanford S., O'Connell B., Benham C.J., et al. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. Eur Mol Biol Organ J 19 (2000) 1034-1044
29. Liu J., He L., Collins I., Ge H., Libutti D., Li J., et al. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell 5 (2000) 331-341
30. Weber A., Liu J., Collins I., and Levens D. TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol 25 (2005) 147-161